Streetbeat News

Analyst Ratings

PEPG

Analysts have provided bullish and somewhat bullish ratings for PepGen (NASDAQ:PEPG) in the last quarter, with an average price target of $24.0, up 41.18% from the previous average of $17.00. The current price of PepGen is $12.2.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 9:00 pm

BLDP

In the last 3 months, 5 analysts have provided 12-month price targets for Ballard Power Systems (NASDAQ:BLDP), with an average target of $5.15, down 14.17% from the previous average of $6.00. The ratings include 1 bullish, 2 indifferent, and 2 somewhat bearish.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 8:02 pm

AMAT

Over the past 3 months, 13 analysts have published their opinion on Applied Mat (NASDAQ:AMAT) stock, with an average 12-month price target of $136.92. The average price target has increased by 6.21% over the past month.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 8:02 pm

DNUT

Over the past 3 months, 7 analysts have published their opinion on Krispy Kreme (NASDAQ:DNUT) stock, with an average price target of $17.57, implying an upside from the current price of $14.055. The average price target has increased by 14.61% over the past month.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 8:01 pm

EPRT

In the last 3 months, 4 analysts have offered 12-month price targets for Essential Props Realty (NYSE:EPRT), with an average price target of $27.81, up 3.31% from the previous average of $26.92. The company has received 2 bullish and 2 somewhat bullish ratings.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 8:01 pm

WPC

In the last quarter, 5 analysts rated W.P. Carey (NYSE:WPC) with an average price target of $81.0, compared to its current price of $70.18. The average price target has decreased by 1.82% from the previous average of $82.50.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 8:01 pm

THC

Tenet Healthcare (NYSE:THC) has received positive analyst ratings in the last quarter, with an average 12-month price target of $83.7, up 18.12% from the previous average of $70.86.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 8:00 pm

AXSM

Axsome Therapeutics (NASDAQ:AXSM) shares are trading higher following a recent corporate presentation where the company provided peak sales estimates for drugs in its portfolio. Mizuho analyst Graig Suvannavejh reiterated a Buy rating and maintained a $95 price target, while Morgan Stanley analyst Vikram Purohit maintained an Equal-Weight rating and raised the price target from $87 to $90.

Portfolio Pulse from Ryan Gustafson

June 14, 2023 | 7:47 pm

SPY

Doubleline Capital's Jeffrey Gundlach predicts the Fed will cut rates if unemployment rises to forecast levels, stating that the Fed was too slow in raising interest rates. He also suggests that persistent weakness in oil prices indicates lower inflation ahead.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 7:43 pm

SPY

Doubleline Capital's Jeffrey Gundlach believes we could be at a turning point for inflation and that the Fed is overstating inflation risk. He also predicts the Fed will cut rates if the unemployment rate rises to their forecast.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 7:42 pm